抑制剂原料药化学品
CAS 登录号 | 产品名称 | 分子式 |
---|
101536-55-4 | 神经激肽B | C55H79N13O14S2 |
1038915-60-4 | Niraparib; 2-[4-((3S)-3-哌啶基)苯基]-2H-吲唑-7-甲酰胺 | C19H20N4O |
1068148-47-9 | BIBP 3226三氟乙酸盐 | C29H32F3N5O5 |
1078-21-3 | 4-氨基-3-苯基丁酸盐酸盐 | C10H14ClNO2 |
109844-92-0 | N-(4-氯苯基)-5-硝基呋喃-2-甲酰胺 | C11H7ClN2O4 |
1152782-19-8 | A1120 | C20H19F3N2O3 |
1197953-54-0 | Brigatinib | C29H39ClN7O2P |
123690-79-9 | CGP-35348 | C8H20NO4P |
1373764-75-0 | 2-(4-羟基苯基)-1-(1,3,4,9-四氢吡啶并[3,4-b]吲哚-2-基)乙酮 | C19H18N2O2 |
142356-40-9 | 2-溴-5,6-二氯-1H-苯并咪唑 | C7H3BrCl2N2 |
1427001-89-5 | AMY-101 | C83H117N23O18S2 |
1441190-66-4 | 环鸟苷单磷酸酯-腺苷单磷酸酯 | C20H24N10O13P2 |
1443290-89-8 | ML67-33 | C18H17Cl2N5 |
157009-81-9 | GPRP乙酯 | C20H35N7O7 |
162359-56-0 | 盐酸芬戈莫德; 2-氨基-2-[2-(4-辛烷基苯基)乙基]-1,3-丙二醇盐酸盐 | C19H33NO2.HCl |
1627580-64-6 | MOTS-C | C101H152N28O22S2 |
1627929-55-8 | PLX51107 | C26H22N4O3 |
1673560-66-1 | PD-1-IN-17 | C13H22N6O7 |
168828-81-7 | (3-氟-4-吗啉-4-基苯基)氨基甲酸苄酯 | C18H19FN2O3 |
1818885-28-7 | ARV-825 | C46H47ClN8O9S |
1821387-73-8 | CU-T12-9 | C17H13F3N4O2 |
1834571-04-8 | Tat-NR2B9c TFA | C107H189F3N42O32 |
183905-31-9 | (S)-1-[(乙酰基氨基)甲基]-2-氯乙基乙酸酯 | C7H12ClNO3 |
186139-09-3 | MSI-1436 | C37H72N4O5S |
1903763-82-5 | 西瑞那韦 | C23H22F4N4O |
1992047-64-9 | MS023 (二盐酸盐) | C17H27Cl2N3O |
2040295-03-0 | 培西达替尼盐酸盐 | C20H16Cl2F3N5 |
2095886-80-7 | 4-(二氟甲基)-L-亮氨酸 | C7H13F2NO2 |
210302-17-3 | BAM15 | C16H10F2N6O |
2169919-21-3 | 瑞武美尼 | C32H47FN6O4S |
2170722-84-4 | 恩拉克定 | C20H21F3N4O |
2226517-76-4 | Sgc-gak-1 | C18H17BrN2O3 |
2259884-03-0 | 马曲肽 | C207H317N45O65 |
2332841-25-3 | TBAJ-876 | C31H37BrN4O7 |
2375421-09-1 | SR-717锂 | C15H8F2LiN5O3 |
2381089-83-2 | 雷他曲肽 | C221H342N46O68 |
259870-32-1 | 2-苯基-N-(吡啶-4-基甲基)喹唑啉-4-胺 | C20H16N4 |
2603528-97-6 | (2S,3R)-1-(3-氰基-6-甲基-4-(三氟甲基)吡啶-2-基)-3-羟基-N-甲基-N-(m-甲苯基)吡咯烷-2-甲酰胺 | C21H21F3N4O2 |
263878-43-9 | 那法瑞林乙酸酯 | C68H87N17O15 |
2761063-79-8 | ELOVL1-IN-2 | C18H15FN2O |
301177-43-5 | ESI-08 | C20H23N3OS |
303094-67-9 | 1-(4,6-二甲基嘧啶-2-基)-3-[2-(三氟甲基)苯基]胍 | C14H14F3N5 |
317318-70-0 | GW 501516; 2-(4-((2-(4-(三氟甲基)苯基)-5-甲基噻唑-4-基)甲基硫基)-2-甲基苯氧基)乙酸 | C21H18F3NO3S2 |
349106-80-5 | 2,2-二氯-N-(3-氯-4-氟苯基)乙酰胺 | C8H5Cl3FNO |
359714-55-9 | CAY10499 | C18H17N3O5 |
363600-92-4 | Tlr2-IN-C29 | C16H15NO4 |
37836-90-1 | 1-(7-甲氧基-4-甲基喹唑啉-2-基)胍 | C11H13N5O |
379270-37-8 | 替诺福韦艾拉酚胺 | C21H29N6O5P |
400827-55-6 | 4-[2-[[(6R,7R)-2-羧基-7-[[(2Z)-(乙氧基亚氨基)[5-(膦酰氨基)-1,2,4-噻二唑-3-基]乙酰基]氨基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]硫基]-4-噻唑基]-1-甲基吡啶鎓乙酸盐水合物 | C22H22N8O8PS4.C2H3O2.H2O |
439081-18-2 | BIBW 2992; N-[4-[(3-氯-4-氟苯基)氨基]-7-[[(3S)-四氢-3-呋喃基]氧基]-6-喹唑啉基]-4-(二甲基氨基)-2-丁烯酰胺 | C24H25ClFN5O3 |
491839-65-7 | WAY-320461 | C15H10BrN3O2S |
51833-76-2 | 血管紧张素1/2+A(2-8)乙酸酯 | C49H71N13O10 |
606143-52-6 | AZD 6244; 5-[(4-溴-2-氯苯基)氨基]-4-氟-N-(2-羟基乙氧基)-1-甲基-1H-苯并咪唑-6-甲酰胺 | C17H15BrClFN4O3 |
612514-42-8 | 3-氨基-N-(1,3-苯并二氧杂环戊烯-5-基甲基)-4,6-二甲基噻吩并[2,3-b]吡啶-2-甲酰胺 | C18H17N3O3S |
654671-77-9 | 磷酸西他列汀一水合物; 7-[(3R)-3-氨基-1-氧代-4-(2,4,5-三氟苯基)丁基]-5,6,7,8-四氢-3-三氟甲基-1,2,4-三唑并[4,3-a]吡嗪磷酸盐一水合物 | C16H15F6N5O.H3PO4.H2O |
684234-60-4 | 2-(4-(4-氯苯基)-1-氧代酞嗪-2(1H)-基)-N-(4-氟苯基)乙酰胺 | C22H15ClFN3O2 |
827022-32-2 | 6-乙酰基-8-环戊基-5-甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]吡啶并[2,3-d]嘧啶-7(8H)-酮盐酸盐 | C24H29N7O2.HCl |
853400-76-7 | 曲非奈肽 | C13H21N3O6 |
857679-55-1 | INCB 8761; PF-4136309; N-[2-[(3S)-3-[[4-羟基-4-[5-(嘧啶-2-基)吡啶-2-基]环己基]氨基]吡咯烷-1-基]-2-氧代乙基]-3-(三氟甲基)苯甲酰胺 | C29H31F3N6O3 |
877399-52-5 | 克里唑替尼; 3-[(R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(哌啶-4-基)-1H-吡唑-4-基]吡啶-2-胺 | C21H22Cl2FN5O |
891016-02-7 | ML-SI3 | C23H31N3O3S |
901599-43-7 | N-(4-甲氧基苯基)喹喔啉-2-甲酰胺 | C16H13N3O2 |
914454-01-6 | 毒蜥外泌肽-4(乙酸酯) | C184H282N50O60S .C2H4O2 |
951441-04-6 | Sephin1 | C8H9ClN4 |
99-52-5 | 4-硝基-2-甲苯胺 | C7H8N2O2 |